<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941110-1-00097</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4702 -->  <!-- PJG ITAG l=11 g=1 f=1 --> (i) Effective January 1, 2003, no person may produce  <!-- PJG 0012 frnewline --> HCFC&hyph;141b except in a process resulting in its transformation,  <!-- PJG 0012 frnewline --> use in a process resulting in destruction, or for exceptions  <!-- PJG 0012 frnewline --> stated in paragraph (p) of this section.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (j) Effective January 1, 2003, no person may import HCFC&hyph;141b  <!-- PJG 0012 frnewline --> except for use in a process resulting in its transformation, use  <!-- PJG 0012 frnewline --> in a process resulting in destruction, or for exceptions stated  <!-- PJG 0012 frnewline --> in paragraph (p) of this section.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (k) Effective January 1, 2010, no person may produce or  <!-- PJG 0012 frnewline --> consume (as defined under &sect;82.3 of this subpart) HCFC&hyph;22 or  <!-- PJG 0012 frnewline --> HCFC&hyph;142b for any purpose other than for use in a process  <!-- PJG 0012 frnewline --> resulting in their transformation, use in a process resulting in  <!-- PJG 0012 frnewline --> their destruction, for use in equipment manufactured prior to  <!-- PJG 0012 frnewline --> January 1, 2010, or for exceptions stated in paragraph (p) of  <!-- PJG 0012 frnewline --> this section in excess of baseline allowances allocated &sect;82.5(h)  <!-- PJG 0012 frnewline --> and &sect;82.6(h).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (l) Effective January 1, 2020, no person may produce or  <!-- PJG 0012 frnewline --> consume (as defined under &sect;82.3 of this subpart) HCFC&hyph;22 or HCFC&hyph;142b for any purpose other than for use in a process resulting in  <!-- PJG 0012 frnewline --> their transformation, use in a process resulting in their  <!-- PJG 0012 frnewline --> destruction or for exceptions stated in paragraph (p) of this  <!-- PJG 0012 frnewline --> section.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (m) Effective January 1, 2015, no person may produce or  <!-- PJG 0012 frnewline --> consume (as under defined under &sect;82.3 of this subpart) class II  <!-- PJG 0012 frnewline --> substances not previously controlled, for any purpose other than  <!-- PJG 0012 frnewline --> for use in a process resulting in its transformation, use in a  <!-- PJG 0012 frnewline --> process resulting in their destruction, as a refrigerant in  <!-- PJG 0012 frnewline --> equipment manufactured before January 1, 2020, or for exceptions  <!-- PJG 0012 frnewline --> stated in paragraph (p) of this section, in excess of baseline  <!-- PJG 0012 frnewline --> production and consumption levels defined in &sect;82.5(h) and  <!-- PJG 0012 frnewline --> &sect;82.6(h).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (n) Effective January 1, 2030, no person may produce or  <!-- PJG 0012 frnewline --> consume class II substances, for any purpose other than for use  <!-- PJG 0012 frnewline --> in a process resulting in their transformation, use in a process  <!-- PJG 0012 frnewline --> resulting in their destruction, or for exceptions stated in  <!-- PJG 0012 frnewline --> paragraph (p) of this section.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (o) Effective January 1, 1996, essential-use allowances are  <!-- PJG 0012 frnewline --> apportioned to a person for the exempted production of specified  <!-- PJG 0012 frnewline --> class I (except class I, Group VI) controlled substances.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (1) Essential-uses for the production of controlled substances  <!-- PJG 0012 frnewline --> as agreed to by the Parties to the Protocol and subject to the  <!-- PJG 0012 frnewline --> periodic revision of the Parties are:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (i) Medical Dose Inhalers_aerosols.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (ii) Space Shuttle_solvents.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (iii) Laboratory and Analytical Applications (see Appendix G  <!-- PJG 0012 frnewline --> of this subpart).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (2) Persons in the following list are allocated essential-use  <!-- PJG 0012 frnewline --> allowances for a specific quantity of a specific class I  <!-- PJG 0012 frnewline --> controlled substances for a specific essential-use exemption:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (i) Metered Dose Inhalers_Aerosols. <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            